Marshall Wace’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $554K | Hold |
128,451
| – | – | ﹤0.01% | 1978 |
|
|
2025
Q1 | $480K | Sell |
128,451
-31,643
| -20% | -$118K | ﹤0.01% | 1979 |
|
|
2024
Q4 | $1.63M | Buy |
160,094
+21,279
| +15% | +$217K | ﹤0.01% | 1412 |
|
|
2024
Q3 | $1.73M | Sell |
138,815
-33,243
| -19% | -$414K | ﹤0.01% | 1312 |
|
|
2024
Q2 | $2.25M | Sell |
172,058
-982
| -0.6% | -$12.8K | ﹤0.01% | 1197 |
|
|
2024
Q1 | $3.92M | Buy |
173,040
+44,588
| +35% | +$1.01M | 0.01% | 963 |
|
|
2023
Q4 | $1.66M | Sell |
128,452
-17,095
| -12% | -$221K | ﹤0.01% | 1076 |
|
|
2023
Q3 | $2.93M | Sell |
145,547
-17,386
| -11% | -$349K | 0.01% | 935 |
|
|
2023
Q2 | $4.37M | Buy |
162,933
+30,606
| +23% | +$822K | 0.01% | 917 |
|
|
2023
Q1 | $7.72M | Sell |
132,327
-15,021
| -10% | -$876K | 0.02% | 697 |
|
|
2022
Q4 | $7.51M | Buy |
147,348
+136,739
| +1,289% | +$6.97M | 0.02% | 846 |
|
|
2022
Q3 | $868K | Buy |
10,609
+9,076
| +592% | +$743K | ﹤0.01% | 1843 |
|
|
2022
Q2 | $103K | Buy |
+1,533
| New | +$103K | ﹤0.01% | 2550 |
|
|
2022
Q1 | – | Sell |
-600
| Closed | -$57K | – | 2967 |
|
|
2021
Q4 | $57K | Buy |
+600
| New | +$57K | ﹤0.01% | 2834 |
|
|
2021
Q1 | – | Sell |
-14,495
| Closed | -$3.37M | – | 2332 |
|
|
2020
Q4 | $3.37M | Buy |
14,495
+13,239
| +1,054% | +$3.07M | 0.02% | 661 |
|
|
2020
Q3 | $275K | Buy |
+1,256
| New | +$275K | ﹤0.01% | 1349 |
|
|
2020
Q1 | – | Sell |
-19,634
| Closed | -$5.65M | – | 1829 |
|
|
2019
Q4 | $5.65M | Buy |
+19,634
| New | +$5.65M | 0.04% | 453 |
|